ALEXANDRIA, Va., Jan. 29 -- United States Patent no. 12,209,072, issued on Jan. 28, was assigned to Bristol-Myers Squibb Co. (Princeton, N.J.).

"Cyclopentyl acids as LPA antagonists" was invented by Peter Tai Wah Cheng (Princeton, N.J.), Robert F. Kaltenbach III (Holland, Pa.), Jun Shi (Pennington, N.J.), Yan Shi (Flourtown, Pa.) and Hao Zhang (Belle Meade, N.J.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention provides compounds of Formula (I) or a stereoisomer, tautomer, or pharmaceutically acceptable salt or solvate thereof, wherein all the variables are as defined herein. These compounds are selective LPA receptor inhibitors."

The patent was filed on Sept. 16, 2019, under Application ...